Study on the Diagnosis and Management of CLL in Italy by GIMEMA

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGruppo Italiano Malattie EMatologiche dell'Adulto

About this trial

retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL.

retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021.

prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years at diagnosis

One of the following diagnoses that meet the international diagnostic criteria (iwCLL2018 and WHO2017)

Chronic lymphocytic leukemia (CLL)

Small lymphocytic lymphoma (SLL)

Disqualifiers

- -

Trial population

All patients with CLL/SLL or MBL diagnosis followed at participant sites starting from January 1st, 2010 (retrospective cohort) and from September 1st, 2021 (prospective cohort).

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Describe the diagnosis and management of CLL patients

evaluation of CLL management in terms of time to first treatment

Time frame
at 1 year for the prospective cohort and at 4 years for the retrospective cohort

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.